Search results
NIH, MSKCC researchers publish AI model for predicting immunotherapy responses
FierceBiotech· 3 hours agoResearchers at the National Institutes of Health and Memorial Sloan Kettering Cancer Center said...
New bowel tumor drug helped cure cancer in 100% of cases
BGR· 2 hours agoA drug called Jemperli (dostarlimab) showed impressive results in a phase 2 trial at the Memorial ...
Weight-loss injections could halve risk of cancer
The Telegraph via Yahoo News· 3 hours agoA study of 75 women with breast cancer by researchers from the Memorial Sloan Kettering Cancer Centre in New York ...
NIH Scientists Develop AI Tool to Predict How Cancer Patients will Respond to Immunotherapy
Sierra Sun Times· 6 hours agoIn a proof-of-concept study, researchers at the National Institutes of Health (NIH) have developed...
GSK’s Jemperli shows potential in Phase II trial for locally advanced rectal cancer
Clinical Trials Arena via Yahoo Finance· 11 hours agoThe drug candidate was found to be 100% effective in treating all patients who were enrolled in the...
Ken Griffin continues healthcare giving with $12M to Hospital for Special Surgery
Becker’s Hospital Review· 13 hours agoThe multiyear gift to the academic medical center will establish the Kenneth C. Griffin Research Accelerator to expedite HSS research and support construction of the HSS Kellen ...
NIH AI tool predicts cancer patients’ immunotherapy outcomes
Pharmaceutical Technology via Yahoo Finance· 12 hours agoThe proof-of-concept study was spearheaded by the Center for Cancer Research at the National Cancer...
GSK reports 100% response in rectal cancer study with Jemperli By Investing.com
Investing.com· 1 day agoGSK plc (LSE/NYSE: LON:GSK) has shared updated results from a phase II study conducted in...
Pfizer drug extends life for patients with rare lung cancer usually seen in nonsmokers
NBC Universal via AOL· 4 days agoPfizer’s lung cancer drug Lorbrena can extend life for patients with a rare form of the disease for...
Weight loss jabs have 'enormous potential' to cut risk of obesity-related cancer
Daily Express· 3 hours agoWeight loss jabs such as Ozempic have “enormous potential” as a new weapon in the fight against ...